Eli Lilly has entered a collaboration with Seamless Therapeutics worth up to $1.12 billion to co-develop gene editing therapies targeting genetic forms of hearing loss. …
Read More
Washington- and California-based Nautilus Biotechnology is teaming up with Weill Cornell Medicine–Qatar and the Michael J. Fox Foundation (MJFF) for Parkinson’s Research on a new research …
Read More
The U.S. Food and Drug Administration has cleared Life Biosciences’ Investigational New Drug application for ER-100, allowing the Boston-based biotechnology company to begin a Phase …
Read More
That’s the headline from Basecamp Research this week, and if it holds up, it’s an important signal for genetic medicine field.
Read More
Menlo Park–based Antheia has added $24 million in a second close of its Series C round, bringing its total raised over the past year to …
Read More
Insilico Medicine has signed a strategic collaboration with Chinese Qilu Pharmaceutical valued at nearly $120 million to co-develop small molecule therapies targeting cardiometabolic diseases. The …
Read More
